30 Years of HIV Progress
From crisis to hope. From the frontlines to the future. Thirty years of progress—and counting.
About the event
Speakers at the conference include:
.jpg)
Prof. Dr. Monica Gandhi
Prof. Dr. Daniel Rauch
Join us for a transformative conversation spanning three decades of HIV/AIDS breakthroughs
In 1996, a medical revolution changed everything. The introduction of triple-drug therapy, known as highly active antiretroviral therapy (HAART), transformed HIV from a death sentence into a manageable chronic condition. Nearly three decades later, we stand at another pivotal moment in HIV prevention and care.
This event brings together two distinguished voices from different frontlines of the epidemic—one who witnessed the darkest days of the crisis firsthand, and one who continues to pioneer the future of HIV treatment and prevention.
What You Will Learn:
•How HAART revolutionized HIV care and what made 1996 a watershed moment
•The evolution of antiretroviral therapy from complex multi-pill regimens to today's
streamlined treatments
•Cutting-edge innovations in HIV prevention, including PrEP and long-acting therapies
•Real stories from the frontlines during the epidemic's darkest hours
•Where we're headed: the future of HIV treatment, prevention, and the pursuit of a cure
Whether you're a healthcare professional, researcher, advocate, or someone seeking to understand one of medicine's greatest success stories, this event offers a rare opportunity to learn from those who have dedicated their careers to turning the tide against HIV/AIDS.
Who Should Join
•Infectious Disease Specialists, HIV/AIDS Clinicians & Physicians, Public Health Officials, Epidemiologists
•Clinical Researchers, Pediatricians (especially pediatric infectious disease), Hospital, Medicine Physicians, Pharmacists (HIV specialty), Nurse Practitioners & Physician Assistants (HIV care), •Healthcare Administrators (HIV programs), Medical Students & Residents
•Global Health Professionals, HIV Prevention Coordinators, Community Health Workers, Medical Educators, Sexual Health Educators, Pharmaceutical Industry Professionals (HIV therapeutics), Policy Makers (healthcare/public health).